Malta - engleski - Medicines Authority

central procurement & supplies unit - benserazide; levodopa - hard capsule - benserazide 25 mg; levodopa 100 mg - anti-parkinson drugs

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - benserazide hydrochloride; levodopa -

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - benserazide hydrochloride 50mg;  ; levodopa 200mg;   - tablet - 250 mg - active: benserazide hydrochloride 50mg   levodopa 200mg  

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - benserazide hydrochloride 25mg;  ;  ; levodopa 100mg;   - dispersible tablet - 125 mg - active: benserazide hydrochloride 25mg     levodopa 100mg   excipient: citric acid magnesium stearate maize starch microcrystalline cellulose

Irska - engleski - HPRA (Health Products Regulatory Authority)

roche products limited - levodopa, benserazide hydrochloride - tablets - 100/25 milligram - dopa and dopa derivatives

Irska - engleski - HPRA (Health Products Regulatory Authority)

roche products limited - levodopa, benserazide hydrochloride - tablets - 50/12.5 milligram - dopa and dopa derivatives

Australija - engleski - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 200 mg; benserazide hydrochloride, quantity: 57 mg (equivalent: benserazide, qty 50 mg) - capsule, hard - excipient ingredients: iron oxide yellow; magnesium stearate; indigo carmine; povidone; gelatin; titanium dioxide; purified talc; microcrystalline cellulose; iron oxide red - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, dispersible - excipient ingredients: citric acid; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - capsule, hard - excipient ingredients: indigo carmine; purified talc; gelatin; iron oxide red; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 50 mg; benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg) - capsule, hard - excipient ingredients: indigo carmine; iron oxide black; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; povidone; mannitol; gelatin - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.